Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Yu Zhu

3PUBLICATIONS

32CO-AUTHORS

Molecular targetsGene and molecular therapy

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Apr 05, 2024

Co-occurring EGFR p.E709X Mutation Mediates Primary Resistance to the Third-Generation EGFR-TKIs in EGFR p.G719X-Mutant Patients with Advanced NSCLC.

Lanlan Pang, Yihua Huang, Weitao Zhuang

|Mar 28, 2022

Low-Temperature Plasma-Activated Medium Inhibited Proliferation and Progression of Lung Cancer by Targeting the PI3K/Akt and MAPK Pathways.

Ying Li, Yang Lv, Yu Zhu

|May 28, 2021

Glutathione-responsive PLGA nanocomplex for dual delivery of doxorubicin and curcumin to overcome tumor multidrug resistance.

Xuandi Lai, Xinran Geng, Mengqing Li

Pageof 1

Frequent Collaborators

2 joint publications

Mengqing Li

1 joint publications

Xuandi Lai

1 joint publications

Xinran Geng

1 joint publications

Mengxiong Tang

1 joint publications

Mengsu Yang

1 joint publications

Lin Shen

1 joint publications

Shubin Wang

1 joint publications

Ying Li

1 joint publications

Yang Lv

1 joint publications

Xiaodong Yang

Frequent Collaborators

2 joint publications

Mengqing Li

1 joint publications

Xuandi Lai

1 joint publications

Xinran Geng

1 joint publications

Mengxiong Tang

Top Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on : Jun 09, 2023

Using <em>In Vitro</em> Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Using <em>In Vitro</em> Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on : Nov 01, 2017

See more related videos

Top Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on : Jun 09, 2023

Using <em>In Vitro</em> Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Using <em>In Vitro</em> Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on : Nov 01, 2017

See more related videos